Anticoagulant therapy of thromboembolic disease during pregnancy

Comprehensive Therapy

Volumn 24, Issue 6-7, 1998, Pages 289-294

  Wehrmacher, William H ^a   Karlman, Roberta L ^a   Scanlon, Patrick ^a   Messmore Jr , Harry L ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULANT THERAPY; EMBRYOPATHY; HUMAN; MATERNAL MORTALITY; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION; REVIEW; THROMBOEMBOLISM;

ADULT; ANTICOAGULANTS; FEMALE; HEPARIN; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RISK FACTORS; THROMBOSIS; WARFARIN;

EID: 0031831735     PISSN: 00988243     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Treffers PE, Huidekoper BL, Weenink GH, et al. Epidemiological observations of thrombo-embolic disease during pregnancy and in the puerperium in 56,022 women. Int J Gynaecol Obstet. 1983;21:327-331.
2. Wehrmacher WH, Messmore H. Thromboembolic disease during pregnancy: problems with anticoagulant therapy. Compr Ther. 1990;10:31-35.
3. Salazar E, Izaguirre R, Verdejo J, et al. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses. J Am Coll Cardiol. 1996;27:1698-1703.
4. Lecuru F, Desnos M, Taurelle R. Anticoagulant therapy in pregnancy: report of 54 cases. Acta Obstet Gynecol Scand. 1996;75:217-221.
5. Ramin SM, Ramin KD, Gilstrap LC. Anticoagulants and thrombolytics during pregnancy. Semin Perinatol. 1997;21: 149-153.
6. Sipes SL, Weiner CP. Venous thromboembolic disease in pregnancy. Semin Perinatol. 1990;14:103-118.
7. Girling JC, de Swiet M. Thromboembolism in pregnancy: an overview. Curr Opin Obstet Gynecol. 1996;8:458-463.
8. Ginsberg JS, Hirsh J. Use of antithrombotic agents during pregnancy. Chest. 1995;108(suppl):305S-311S.
9. Hellgren M, Svensson PG, Dahlback B. Resistance to activated protein C as a basis for venous thromboembolism associated with pregnancy and oral contraceptives. Am J Obstet Gynecol. 1995;173:210-213.
10. Peek MJ, Nelson-Piercy C, Manning RA, et al. Activated protein C resistance in normal pregnancy. Br J Obstet Gynaecol. 1997;104:1084-1086.
11. Brancazio LR, Roperti KA, Stierer R, et al. Pharmacokinetics and pharmacodynamics of subcutaneous heparin during the early third trimester of pregnancy. Am J Obstet Gynecol. 1995;173:1240-1245.
12. Elkayam UR. Anticoagulation in pregnant women with prosthetic heart valves: a double jeopardy. J Am Coll Cardiol. 1996;27:1704-1706.
13. Howe AM, Lipson AH, de Silva M, et al. Severe cervical dysplasia and nasal cartilage calcification following prenatal warfarin exposure. Am J Med Genet. 1997;71:391-396.
14. Menger H, Lin AE, Toriello HV, et al. Vitamin K deficiency embryopathy: a phenocopy of the warfarin embryopathy due to a disorder of embryonic vitamin K metabolism. Am J Med Genet. 1997;72:129-134.
15. Ginsberg J, Hirsh J. Anticoagulant therapy during pregnancy. In: Verstraete M, Fuster V, Topol E, eds. Cardiovascular Thrombosis, Thrombocardiology, and Thromboneurology. 2nd ed. Philadelphia, Pa: Lippincott-Raven Publishers; 1998.
16. Dahlman TC. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol. 1993;168:1265-1270.
17. Shefras J, Farquharson RG. Bone density studies in pregnant women receiving heparin. Eur J Obstet Gynecol Reprod Biol. 1996;65:171-174.
18. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med. 1997;336:1506-1511.
19. Spandorfer J, Merli G. Anticoagulation and elective surgery. N Engl J Med. 1997;337:938-939.
20. Greinacher A, Eckhardt T, Mussmann J, et al. Pregnancy complicated by heparin-associated thrombocytopenia: management by a prospectively in vitro selected heparinoid (Org 10172). Thromb Res. 1993;71:123-126.
21. Hatjis CG. Heparin-induced thrombocytopenia in pregnancy: a case report. J Reprod Med. 1984;29:337-338.
22. Warkentin TE, Chong BH, Greinacher A. Heparin-induced thrombocytopenia: towards consensus. Thromb Haemost. 1998;79:1-7.
23. Kutten WH. Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone. Am J Obstet Gynecol. 1996;174:1584-1589.
24. Devine DV, Brigden ML. The antiphospholipid syndrome: when does the presence of antiphospholipid antibodies require therapy? Postgrad Med. 1996;99:105-108.
25. Anderson DR, Ginsberg JS, Brill-Edwards P, et al. The use of an indwelling Teflon catheter for subcutaneous heparin administration during pregnancy: a randomized crossover study. Arch Intern Med. 1993;153:841-844.
26. Messmore HL, Koza M, Farid S, et al. Utility of the Heptest and a chromogenic substrate method to assess anticoagulation in patients refractory to heparinization by the activated partial thromboplastin time method. Semin Thromb Hemost. 1994;20:351-352.
27. Nelson-Piercy C, Letsky EA, de Swiet M. Low-molecular-weight heparin for obstetric thrombophrophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk. Am J Obstet Gynecol. 1997;176:1062-1068.
28. Harenberg J, Huhle G, Piazolo L, et al. Long-term anticoagulation of outpatients with adverse events to oral anticoagulants using low-molecular-weight heparin. Semin Thromb Hemost. 1997;23:167-172.
29. Rhone-Poulenc's warning letter to physicians regarding the LMWH, enoxaparine.
30. Sturridge F, de Swiet M, Letsky E. The use of low molecular weight heparin for thromboprophylaxis in pregnancy. Br J Obstet Gynaecol. 1994;101:69-71.
31. Lee LH, Liauw PC, Ng AS. Low molecular weight heparin for thromboprophylaxis during pregnancy in 2 patients with mechanical mitral valve replacement. Thromb Haemost. 1996;76:628-630.
32. Fejgin MD, Lourwood DL. Low molecular weight heparins and their use in obstetrics and gynecology. Obstet Gynecol Surv. 1994;49:424-431.
33. Anand SS, Brimble S, Ginsberg JS. Management of iliotemoral thrombosis in a pregnant patient with heparin resistance. Arch Intern Med. 1997;157:815-816.